Tanya Dorff, MD, on Androgen Deprivation, External-Beam Radiation Therapy, and Oligometastatic Hormone-Sensitive Prostate Cancer

Posted: Thursday, September 1, 2022

Tanya Dorff, MD, of City of Hope, discusses the challenges posed when treating patients with oligometastatic prostate cancer, for whom lifelong intensive therapy may not be appropriate. Dr. Dorff reviews several recent studies, the need for the most sensitive imaging tools, and the complex treatment landscape that makes it more important than ever to enroll patients in clinical trials that may help better define best practices.